<DOC>
	<DOCNO>NCT00116675</DOCNO>
	<brief_summary>The primary purpose study evaluate effectiveness pediatric subject three different strength resiquimod gel applied common wart ( ) three time week four week . A second purpose evaluate safety drug .</brief_summary>
	<brief_title>Four Week Safety Efficacy Study With Topical Gel Treat Common Warts Pediatric Subjects</brief_title>
	<detailed_description />
	<mesh_term>Warts</mesh_term>
	<criteria>Diagnosis common wart Ages 3 11 Other type wart ( ) , ie . plantar Currently participate another clinical study Chronic viral hepatitis B C</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Common Wart ( )</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Wart ( )</keyword>
	<keyword>Children</keyword>
	<keyword>3M Pharmaceuticals</keyword>
	<keyword>Resiquimod</keyword>
</DOC>